The Coronavirus disease 2019 (COVID-19), the highly contagious infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to many devastating consequences and a significant decrease in the access and search for diagnosis and treatment of other diseases that also have a historically major impact on public health, such as cancer. So we aimed to study the postoperative complications in post COVID-19 positive cancer patients. This retrospective observational, cross-sectional, non-comparative study, carried out in the department of surgical oncology, Acharya Harihar Post Graduate Institute of Cancer for a duration of one year from 1st July 2020 till 30th June 2021. Results: Out of 760 patients, 60 (7.9%) patients tested positive for COVID-19 during this study period. Fourteen patients out of 60 were operated on after being COVID-19 negative and after 4 weeks of the initial positive test. Out of these 14 patients, (six carcinoma breast, three carcinoma stomach, two carcinoma rectosigmoid, one carcinoma jejunum, one carcinoma colon, and one head and neck cancer), seven patients were female and seven were male. The post-operative course was uneventful in all 14 patients apart from minor postoperative complications. In this study, no COVID-19 related morbidity or mortality was observed in electively operated patients. So, based on this data, the beneficial role of mandatory testing for COVID-19 before elective cancer surgery can be concluded.